Kutatási jelek – Signal Engine

• Tumor biology and oncogenesis of neuroblastoma - Institut Curie — Neuroblastoma
• Waldenström Macroglobulinemia Clinical Trials — Waldenstrom macroglobulinemia
• New drug for prostate cancer patients in clinical trials — Prostate cancer
• Trials Archive — Cholangiocarcinoma
• GORTEC Announces New Trial Success for Head and Neck Cancer Treatment — Head and neck squamous cell carcinoma
• Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial — Head and neck squamous cell carcinoma
• ASH 2024: New Research, Data Drive Progress in Myelofibrosis — Myelofibrosis
• INITIALL: Risk-based Pediatric Leukemia/Lymphoma Treatment — Leukemia
• Sotorasib/Panitumumab Resistance May Be Linked to Genomic Alterations in KRAS G12C+ mCRC — Colorectal cancer
• Proving the Concept: A Sampler of Early-Stage Science at AACR 2025 — Head and neck squamous cell carcinoma
• Potential differences between real-life and randomized controlled trial populations in chronic myeloid leukemia — Chronic myeloid leukemia
• Key insights from head and neck research at ASCO 2025 - ecancer — Head and neck squamous cell carcinoma
• A LDH‑Based Supramolecular Photosensitizer‑Functionalized Bioactive Glass Scaffold for Integrated Postoperative Osteosarcoma Recurrence Prevention and Bone Regeneration — Osteosarcoma
• Engineering Osteoimmune Responses with Functionalized Orthopedic Implants for Post‑Operative Osteosarcoma Treatment — Osteosarcoma
• Targeting serine synthesis pathway to reverse paclitaxel resistance in NSCLC with combination of paclitaxel and anlotinib — NSCLC
• Advancements in single-cell sequencing for cervical cancer research — Cervical cancer
• Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome — NSCLC
• Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, nearly-stage classical Hodgkin lymphoma — Hodgkin lymphoma
• Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma — Mantle cell lymphoma
• Tebentafusp in Metastatic Uveal Melanoma: A Meta-analysis — Melanoma